Clinical Trials Directory

Trials / Unknown

UnknownNCT06186115

Intraarticular Gold Microparticles for Hip Osteoarthritis

Intraarticular Gold Microparticles for Hip Osteoarthritis - a 2-year Follow-up Pilot Study.

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Northern Orthopaedic Division, Denmark · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

In a pilot study, the investigators recently showed that intraarticular metallic gold microparticles reduce knee osteoarthritis pain for up to two years and found associated significant proteomic changes in serum and synovial fluid within eight weeks. This study aim to evaluate the outcome after intra-articular injection of gold microparticles for hip osteoarthritis.

Detailed description

A cohort of 20 patients, aged ≥ 18 years, with pain ≥ 3 months, and Kellgren-Lawrence OA grade 2-4, will beincluded. Metallic gold 20 mg, 72.000 pieces, 20-40 µ-meter (Berlock-Micro-Implants, HumanGoldInject) (1) were injected into the hip joint using hyaluronic acid as the carrier. In total, we treated 24 hip joints. The primary outcome was the Western Ontario and McMaster Universities Arthritis Index (WOMAC).

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTGoldIntra articular

Timeline

Start date
2024-03-04
Primary completion
2024-04-01
Completion
2024-05-01
First posted
2023-12-29
Last updated
2024-01-30

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT06186115. Inclusion in this directory is not an endorsement.